Plain-English translation of NCT06980649 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.
This is an early-stage study testing a new medication called in people who have been diagnosed with Graves' Disease, a condition where the immune system causes the thyroid to produce too much hormone. Researchers want to learn whether the medication is safe to use and how it affects the disease. About 15 people will participate in this open-label study, meaning both you and your doctors will know you're receiving the treatment.
Graves' Disease can cause serious symptoms like rapid heartbeat, anxiety, and weight loss, and current treatment options don't work well for everyone. This trial is exploring whether this new medication could offer another way to help control the overactive thyroid.
You likely qualify if…
You likely don't qualify if…
You will receive the medication as part of this study. Researchers will monitor you carefully to check if the medication is safe and how it affects biomarkers (measurable signs in your blood that show how your disease is responding). The study will involve regular clinic visits where your blood will be tested and your health will be assessed.
AI-generated summary from trial data · Aug 26, 2026 · Not medical advice
United States